REARDON ANDREW (CLO & Secretary) reported 1 transaction at LIGAND PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 7/2/2025ACC: 0002001011-25-000052
Officer· CLO & Secretary
Since Mar 2026
+233.00
Net shares
Net buyer
$21.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
233.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+233.00
Price / share
$91.08
Trade value
$21.22K
% of position
0.7%
6/30/2025
31.90K→32.14K
Total
Net shares
+233.00
Net value
$21.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2025 | J · J | +233.00 | $91.08 | $21.22K | 0.7% | 31.90K | 32.14K |
| Total | +233.00 | $21.22K | ||||||
Derivative Transactions0
No derivative transactions reported